Us2.ai: FDA-cleared AI decision support to process full echo reports with zero clicks in under 2 minutes1 SINGAPORE--(BUSINESS WIRE)--Us2.ai, a Singapore-based medtech firm backed by IHH Healthcare, Heal Partners and...

Nick Anderson, Ph.D., joins PathAI as Vice President of Regulatory Affairs and Hisani Madison, Ph.D., MPH, joins as Franchise Head of Precision Oncology. BOSTON--(BUSINESS WIRE)--PathAI, a leading provider of AI-powered pathology tools to...

PathAI co-founder Khosla carves a new path as CTO of Iterative Scopes At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him away from PathAI, the company he helped start half a decade...

Today marks the beginning of a new era in the field of cancer diagnosis and precision medicine with the coming together of two leading organizations Crosscope Inc. a Silicon Valley-based leader and provider of Vendor Agnostic AI-enabled Digital...

Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret the clinical significance of somatic mutations in cancer. The tool, known as CancerVar, incorporates machine learning...

Paige: Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry NEW YORK–(BUSINESS WIRE)–Paige, a global leader in AI applications in pathology, today...